In preclinical investigations requiring rigorous molecular accuracy, obtaining kpv third party tested compound material is essential to eliminate analytical artifacts and ensure reproducible data. PX1 Research supplies high-purity Lys-Pro-Val tripeptide accompanied by transparent, lot-specific verification from accredited ISO 17025 testing facilities.
In preclinical investigations requiring rigorous molecular accuracy, obtaining kpv third party tested compound material is essential to eliminate analytical artifacts and ensure reproducible data. PX1 Research supplies high-purity Lys-Pro-Val tripeptide accompanied by transparent, lot-specific verification from accredited ISO 17025 testing facilities.
When acquiring kpv third party tested material for laboratory research, investigators receive C-terminal alpha-MSH tripeptide (Lys-Pro-Val) verified by independent ISO 17025 laboratories using reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS). Every lot must demonstrate >99% purity, confirmed identity, and strictly documented endotoxin levels (<0.05 EU/mg) to prevent confounding cellular or animal assay outcomes.
Analytical transparency is paramount when evaluating short signaling sequences. Because synthetic peptides can retain residual reagents, truncated fragments, or heavy metals from solid-phase peptide synthesis (SPPS), independent batch validation ensures that experimental results reflect the genuine biological activity of the sequence rather than synthesis impurities. Laboratories ordering from PX1 Research receive batch-specific Certificates of Analysis (COAs) generated by accredited third-party facilities prior to experimental deployment.
KPV is a tripeptide comprising the C-terminal amino acid sequence (Lysine-Proline-Valine) of alpha-melanocyte-stimulating hormone (alpha-MSH). With a molecular weight of approximately 341.45 g/mol, it represents one of the smallest bioactive peptide fragments derived from the pro-opiomelanocortin (POMC) precursor protein. In vitro studies demonstrate that despite lacking the full melanocortin receptor-binding core of intact alpha-MSH, KPV retains potent biological activity without inducing melanogenesis.
The primary sequence relies on the specific spatial arrangement of the lysine residue's basic side chain alongside the rigid pyrrolidine ring of proline. This spatial conformation allows the tripeptide to enter target cells via specialized transporter channels—such as the human peptide transporter 1 (PepT1)—and interact with intracellular signaling cascades. To confirm structural fidelity before starting binding assays, researchers rely on third-party verified peptides validated by mass spectrometry to confirm the exact monoisotopic mass.
Preclinical studies suggest that KPV exerts its primary biological effects through the intracellular inhibition of nuclear factor kappa B (NF-κB). NF-κB is a master transcriptional regulator responsible for upregulating proinflammatory cytokines, including TNF-alpha, IL-1 beta, IL-6, and IL-8. In vitro assays using intestinal epithelial cell cultures indicate that KPV translocates into the cytoplasm, where it blocks the phosphorylation and degradation of IκB-alpha, thereby preventing NF-κB p65 translocation into the nucleus.
In addition to NF-κB inhibition, preclinical models demonstrate that KPV can modulate mitogen-activated protein kinase (MAPK) signaling pathways, specifically downregulating p38 MAPK phosphorylation. This dual pathway regulation attenuates the transcription of pro-inflammatory enzymes such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). When evaluating these pathway interactions in vitro, utilizing a verified kpv third party tested lot ensures that cytokine suppression is attributable solely to the tripeptide sequence and not to trace bacterial lipopolysaccharides (LPS).
A primary focus of KPV literature centers on mucosal immunology and intestinal epithelial barrier preservation. Rodent models of dextran sulfate sodium (DSS)-induced and trinitrobenzene sulfonic acid (TNBS)-induced colitis have demonstrated that KPV administration reduces histological inflammatory scores, attenuates myeloperoxidase (MPO) activity, and preserves mucosal architecture.
In vitro models utilizing Caco-2 cell monolayers reveal that KPV upregulated the expression of key tight junction proteins, including zonula occludens-1 (ZO-1), occludin, and claudin family members. By reinforcing tight junction stability, the tripeptide reduces paracellular permeability across damaged epithelial sheets. Researchers exploring gut epithelial dynamics frequently reference gut barrier peptides in comparative studies to measure transepithelial electrical resistance (TEER) under inflammatory stress.
To establish true scientific validity, every lot of KPV undergoes rigorous characterization. Reverse-phase high-performance liquid chromatography (RP-HPLC) is utilized to evaluate chemical purity. In RP-HPLC analysis, the sample is passed through a non-polar stationary phase using a polar mobile gradient. Peptide fragments and impurities elute at distinct retention times based on hydrophobicity, yielding a chromatographic profile where the main peak area must exceed 99.0% of the total integrated peak area.
Electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is subsequently conducted to confirm exact molecular mass. ESI-MS generates multicharged ions, producing a mass spectrum that directly matches the theoretical molecular weight of Lys-Pro-Val (341.45 Da). PX1 Research attaches these complete RP-HPLC chromatograms and mass spectra to every lot, enabling researchers to verify high purity research peptides prior to reconstitution.
Endotoxins, or lipopolysaccharides (LPS), are hydrophobic membrane components of Gram-negative bacteria that frequently contaminate synthetic peptides during production or purification. In immunological and barrier function experiments, trace endotoxins introduce severe experimental bias by activating Toll-like receptor 4 (TLR4), triggering systemic inflammatory cascades independent of the test compound.
For research involving NF-κB pathways or cytokine production, unquantified endotoxins render experimental data uninterpretable. PX1 Research enforces stringent bacterial endotoxin testing via Chromogenic Reagent Limulus Amebocyte Lysate (LAL) assays on all lots. Only batches demonstrating endotoxin levels strictly below <0.05 EU/mg are approved for distribution, assuring investigators that observed cell responses originate purely from the tripeptide.
When designing protocols for inflammatory modulation or tissue architecture preservation, researchers often compare KPV against other established gastrointestinal and anti-inflammatory research peptides. For instance, BPC-157 is extensively studied in animal models for promoting angiogenesis and collagen synthesis along damaged mucosal linings, whereas Larazotide acetate functions specifically as a tight junction regulator targeting zonulin pathways. Additionally, Vasoactive Intestinal Peptide acts through class B GPCRs to modulate intestinal immune homeostasis. While BPC-157 and Larazotide target structural remodeling and tight junction assembly, KPV acts directly on intracellular NF-κB transactivation via PepT1 transport, making it a unique tool for dissecting cytokine-driven epithelial dysfunction.
Research-grade KPV is supplied as a lyophilized (freeze-dried) powder to maximize chemical stability. For long-term preservation, un-reconstituted vials should be stored at -20°C or -80°C in a desiccated environment. Lyophilized peptides stored under these conditions maintain chemical integrity for extended periods, minimizing degradation from hydrolysis or oxidation.
Reconstitution protocols require sterile, laboratory-grade solvents such as Bacteriostatic Water, Sterile Water for Injection, or Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream in vitro or in vivo assay. Upon adding the solvent along the inner glass wall of the vial, gentle swirling should be employed; aggressive vortexing must be avoided to prevent mechanical shearing or peptide aggregation. Reconstituted aliquots should be stored at 4°C for short-term use (1–2 weeks) or flash-frozen in single-use working volumes at -80°C to avoid repeated freeze-thaw cycles.
Reliability in preclinical sourcing extends beyond chemical purity to encompass supply chain security and batch traceability. PX1 Research manufactures research compounds within GMP-compliant facilities subject to strict environmental controls. Every synthesis batch is assigned a unique lot number that directly corresponds to its third-party ISO 17025 testing documentation.
To ensure rapid delivery without compromising ambient stability, PX1 Research operates distribution hubs out of California and Arizona. All orders placed Monday through Friday before 12:00 PM PST feature same-day dispatch. Institutional labs requiring bulk quantities or dedicated lot reservation can coordinate directly via PX1 Research wholesale services.
What does 'third-party tested' mean for KPV research peptides?
Third-party tested means that the KPV tripeptide is independently analyzed by an ISO 17025-accredited laboratory unaffiliated with the manufacturer. Testing includes RP-HPLC for purity, Mass Spectrometry for sequence verification, and LAL assays for endotoxin quantification.
What purity level should be expected for kpv third party tested lots?
Research-grade KPV should consistently demonstrate a purity of ≥98.0% (and ideally >99.0%) by RP-HPLC peak area integration, ensuring that raw material lacks truncated peptide fragments or synthetic side-products.
Why is endotoxin testing critical when ordering KPV for cell culture research?
Endotoxins (LPS) activate TLR4 receptors, causing cellular inflammatory responses that mask or distort KPV's actual anti-inflammatory effects. Reliable KPV must test under <0.05 EU/mg to ensure valid assay results.
How should lyophilized KPV be stored upon receipt in the laboratory?
Lyophilized KPV powder should be stored in a freezer at -20°C or -80°C. Vials should be allowed to equilibrate to room temperature before opening to prevent moisture condensation inside the container.
What reconstituted solvents are recommended for KPV in preclinical assays?
KPV readily dissolves in sterile water, bacteriostatic water, or standard buffered saline (PBS, pH 7.4). Solvents should be selected based on the specific requirements of the target cellular or animal model.
How can researchers view the COA for a specific lot of KPV?
PX1 Research provides accessible Certificates of Analysis directly on the product page or upon request, matching the exact lot number printed on the physical vial label.
Is KPV derived from alpha-MSH, and does it bind to melanocortin receptors?
KPV is the C-terminal tripeptide of alpha-MSH. However, preclinical studies indicate it acts primarily via intracellular PepT1 transporter uptake and NF-κB inhibition rather than classic melanocortin receptor (MC1R-MC5R) activation.
Where does PX1 Research ship kpv third party tested orders from?
All PX1 Research products are stored and dispatched directly from domestic fulfillment centers located in California and Arizona, with same-day dispatch available Monday through Friday for orders placed before cutoff.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.